The Centers for Medicare & Medicaid Services announced on Tuesday, July 29, 2026, that the Trump administration will end a Medicare Part D subsidy program at the close of 2026.
Federal officials confirmed the conclusion of the Part D Premium Stabilization Demonstration, returning prescription drug coverage to standard market conditions for the 2027 plan year.
The decision affects around 25 million Americans enrolled in standalone Medicare Part D plans and another 31 million in Medicare Advantage plans.
CMS stated that after reviewing preliminary 2027 plan bids, private insurers demonstrated the ability to price plans independently without government backing.
Federal projections set the national base beneficiary premium at $41.33 for 2027, with annual increases capped at 6% under current law.
Final individual plan premiums will be released in September.
Administration Defends Move
CMS Administrator Dr. Mehmet Oz defended the policy on social media, asserting that government intervention in the prescription plan market was no longer required.
"We are stabilizing the market so this bailout is no longer needed.
Premiums will go up by less than $10 for most Medicare recipients, with many even seeing lower premiums," said Dr. Oz.
Market analysts from The Wall Street Journal reported that nearly half of enrollees in standalone Part D plans are likely to experience premium increases between $11 and $20 per month.
Non-profit healthcare policy researchers at KFF noted that rising standalone plan costs could accelerate enrollment shifts toward privatized Medicare Advantage offerings.
Democratic Party officials and healthcare consumer advocacy representatives strongly criticized the subsidy termination as a financial blow to elderly citizens on fixed incomes.
"Trump and Republicans are doing everything they can to make health care unaffordable for Americans, especially for seniors," said Kendall Witmer, Rapid Response Director at the Democratic National Committee.
Democratic leadership argued that removing the premium cap exposes working families to compound financial pressures from medical debt and rising living expenses.
"Trump and Republicans’ massive healthcare cuts have pushed working families to the brink as they grapple with skyrocketing insurance premiums, even bigger medical bills, and rising prescription drug costs," Witmer added.
Senior advocacy leaders emphasized that incremental monthly rate spikes force vulnerable populations into direct choices between basic necessities and critical medications.
"Trump and Republicans continue to force seniors to pay more while handing tax breaks to billionaires and big corporations," said Leslie Dach, Chair of Protect Our Care.
Organization representatives stressed the immediate financial impact of ending the subsidy program created under the Inflation Reduction Act, which had previously reduced average Part D premiums by over 25% during the current year.
"In the middle of a GOP-induced affordability crisis, they are eliminating a key program that helps seniors afford their medications," Dach said.
Industry trade group AHIP confirmed it is reviewing the administrative change, while major carriers like UnitedHealth Group, Humana, and CVS Health prepare for the upcoming fall open enrollment period.
